Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Buy
38,812
+1,147
+3% +$393K 1.08% 29
2026
Q1
$13.3M Buy
37,665
+1,357
+4% +$484K 1.09% 28
2025
Q4
$11.9M Buy
36,308
+476
+1% +$151K 0.99% 30
2025
Q3
$10.1M Buy
35,832
+650
+2% +$189K 0.88% 35
2025
Q2
$9.82M Buy
35,182
+361
+1% +$102K 0.92% 33
2025
Q1
$10.8M Sell
34,821
-32
-0.1% -$9.45K 1.09% 28
2024
Q4
$9.08M Sell
34,853
-172
-0.5% -$51K 0.89% 34
2024
Q3
$11.3M Buy
35,025
+11,979
+52% +$3.92M 1.02% 28
2024
Q2
$7.2M Sell
23,046
-8,819
-28% -$2.59M 0.78% 35
2024
Q1
$9.06M Buy
31,865
+14,592
+84% +$4.27M 0.91% 30
2023
Q4
$4.97M Buy
17,273
+3,125
+22% +$851K 0.65% 44
2023
Q3
$3.8M Buy
14,148
+10,486
+286% +$2.62M 0.55% 51
2023
Q2
$813K Sell
3,662
-3,475
-49% -$806K 0.15% 100
2023
Q1
$1.73M Sell
7,137
-494
-6% -$121K 0.36% 68
2022
Q4
$2M Buy
7,631
+459
+6% +$123K 0.48% 43
2022
Q3
$1.62M Buy
7,172
+604
+9% +$146K 0.43% 48
2022
Q2
$1.6M Sell
6,568
-74
-1% -$18.1K 0.41% 53
2022
Q1
$1.61M Buy
6,642
+3,801
+134% +$873K 0.36% 61
2021
Q4
$639K Sell
2,841
-53
-2% -$11.2K 0.14% 103
2021
Q3
$615K Sell
2,894
-296
-9% -$68.1K 0.14% 108
2021
Q2
$778K Hold
3,190
0.18% 96
2021
Q1
$794K Sell
3,190
-250
-7% -$59.7K 0.2% 92
2020
Q4
$791K Buy
3,440
+428
+14% +$98.7K 0.2% 94
2020
Q3
$766K Buy
3,012
+292
+11% +$72.3K 0.17% 110
2020
Q2
$641K Buy
2,720
+5
+0.2% +$1.14K 0.14% 110
2020
Q1
$551K Buy
2,715
+3
+0.1% +$655 0.16% 114
2019
Q4
$654K Buy
2,712
+624
+30% +$138K 0.15% 113
2019
Q3
$404K Hold
2,088
0.12% 117
2019
Q2
$385K Sell
2,088
-14
-0.7% -$2.51K 0.11% 120
2019
Q1
$399K Buy
+2,102
New +$401K 0.12% 107

Other funds holding AMGN

SlateStone Wealth's AMGN Position: Q2 2026 in Review

SlateStone Wealth increased its Amgen (AMGN) stake by 3% in Q2 2026, buying an estimated $393K and bringing the position to 38,812 shares worth $14.1M. The position accounts for 1.08% of the portfolio, ranked #29.

SlateStone Wealth first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SlateStone Wealth held 38,812 shares of Amgen worth $14.1M as of Q2 2026.
  • SlateStone Wealth bought 1,147 Amgen shares in Q2 2026, an estimated $393K.
  • Amgen made up 1.08% of SlateStone Wealth's portfolio in Q2 2026, its #29 holding.
  • SlateStone Wealth first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.